Uy Edward, Go Rory
Advanced Vision Laser Center, Manila, Philippines.
J Refract Surg. 2009 Jan;25(1 Suppl):S148-55. doi: 10.3928/1081597X-20090115-13.
To investigate the refractive outcomes and spherical aberration of multifocal LASIK to create a distant-dominant center and near-dominant periphery in hyperopic, myopic, and emmetropic presbyopia.
One hundred ninety-five eyes with myopic presbyopia and 119 eyes with hyperopic or emmetropic presbyopia that underwent LASIK or epithelial LASIK (epi-LASIK) were assessed out to 3 months postoperatively. All eyes underwent the pseudoaccommodative cornea (PAC) treatment using aspheric ablation profiles and wavefront correction with the NIDEK CXIII excimer laser. Mean preoperative spherical equivalent refraction was -3.80+/-2.10 diopters (D) for myopic presbyopia and +1.00+/-0.92 D for hyperopic or emmetropic presbyopia.
Mean postoperative spherical equivalent refraction was -0.40+/-0.77 D for myopic presbyopia and +0.15+/-0.62 D for hyperopic or emmetropic presbyopia. Functional vision, defined as 20/30 or better distance uncorrected visual acuity (UCVA) combined with J3 or better near UCVA, was achieved in 162 (83%) eyes with myopic presbyopia and 103 (87%) eyes with hyperopic or emmetropic presbyopia. An induction of 0.312 microm of spherical aberration was noted at 6 mm for myopic presbyopia treatments and 0.016 microm for hyperopic presbyopia treatments.
The distance-dominant center used for PAC treatments is effective in emmetropic, myopic, and hyperopic presbyopia. The induced spherical aberration allows for depth of focus in patients with presbyopia.
研究多焦点准分子原位角膜磨镶术(LASIK)在远视、近视和正视性老视眼中创建以远视力为主的中心和以近视力为主的周边的屈光结果及球差情况。
对195只近视性老视眼和119只远视或正视性老视眼进行了LASIK或准分子上皮下角膜磨镶术(epi-LASIK),术后随访3个月。所有眼睛均使用非球面消融模式和NIDEK CXIII准分子激光进行波前像差校正的模拟调节角膜(PAC)治疗。近视性老视眼术前平均等效球镜度为-3.80±2.10屈光度(D),远视或正视性老视眼为+1.00±0.92 D。
近视性老视眼术后平均等效球镜度为-0.40±0.77 D,远视或正视性老视眼为+0.15±0.62 D。功能性视力定义为未矫正远视力(UCVA)达到20/30或更好且未矫正近视力(UCVA)达到J3或更好,195只近视性老视眼中有162只(83%)达到此标准,119只远视或正视性老视眼中有103只(87%)达到此标准。近视性老视眼治疗在6 mm处球差诱导为0.312μm,远视性老视眼治疗为0.016μm。
用于PAC治疗的以远视力为主的中心在正视、近视和远视性老视眼中均有效。诱导的球差可为老视患者提供焦深。